PMID: 11913731Mar 27, 2002Paper

Serotonin transporter gene associated with lithium prophylaxis in mood disorders

The Pharmacogenomics Journal
A SerrettiE Smeraldi

Abstract

The aim of this study was to investigate the possible association between the functional polymorphism in the upstream regulatory region of the serotonin transporter gene (5-HTTLPR) and the prophylactic efficacy of lithium in mood disorders. Two hundred and one subjects affected by bipolar (n = 167) and major depressive (n = 34) disorder were followed prospectively for an average of 58.2 months and were typed for their 5-HTTLPR variant using polymerase chain reaction techniques. 5-HTTLPR variants were associated with lithium outcome (F = 5.35; df = 2,198; P = 0.005). Subjects with the s/s variant showed a worse response compared to both l/s and l/l variants. Consideration of possible stratification effects such as sex, polarity, age at onset, duration of lithium treatment and previous episodes did not influence the observed association. 5-HTTLPR variants may be a possible influencing factor for the prophylactic efficacy of lithium in mood disorders.

References

Jul 1, 1978·Archives of General Psychiatry·J Endicott, R L Spitzer
Nov 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·R C YoungD A Meyer
Oct 21, 1991·Nucleic Acids Research·D K Lahiri, J I Nurnberger
Jul 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·R A O'ConnellB E O'Brien
Jan 1, 1990·Journal of Psychiatric Research·Y OdagakiI Yamashita
Jun 1, 1990·Journal of the American College of Cardiology·J F Goodwin
Jan 1, 1989·Progress in Neuro-psychopharmacology & Biological Psychiatry·G M Goodwin
Aug 1, 1988·The Journal of Hospital Infection·J Cohen
Feb 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·C PageF Lappin
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Apr 1, 1984·Journal of Affective Disorders·E SmeraldiK K Kidd
Oct 1, 1984·Journal of Affective Disorders·E SmeraldiA Orsini
Aug 1, 1982·Archives of General Psychiatry·J F LeckmanM M Weissman
Oct 1, 1994·Journal of Affective Disorders·P GrofM Walsh
Dec 1, 1994·Journal of Affective Disorders·L FranchiniE Smeraldi
Nov 1, 1993·International Clinical Psychopharmacology·C Benkelfat
Jun 1, 1993·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M GasperiniE Smeraldi
Apr 1, 1996·Nature Genetics·N Risch, D Botstein
Jun 1, 1996·Journal of Neurochemistry·A HeilsK P Lesch
Apr 9, 1996·American Journal of Medical Genetics·J R KelsoeJ A Egeland
Mar 15, 1997·Biological Psychiatry·F BellivierJ M Launay
May 1, 1997·Molecular Psychiatry·E H CookB L Leventhal
Oct 10, 1997·Molecular Psychiatry·S MatsushitaS Higuchi
Oct 28, 1997·American Journal of Medical Genetics·L OrucC Van Broeckhoven

❮ Previous
Next ❯

Citations

Jun 11, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Martin AldaL Trevor Young
Mar 23, 2002·European Journal of Pharmacology·Alessandro SerrettiEnrico Smeraldi
Jul 26, 2002·Psychiatry Research·Cristina CusinEnrico Smeraldi
Apr 30, 2005·Pharmacogenetics and Genomics·Alessandro SerrettiRoberto Quartesan
Apr 15, 2008·Pharmacogenetics and Genomics·Gilad SilberbergRuth Navon
May 1, 2011·Therapeutic Advances in Chronic Disease·Sarah K TigheJames B Potash
Aug 21, 2009·Genome Medicine·Cristiana CruceanuGustavo Turecki
Dec 21, 2002·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Toshihiro DohiKatsuya Morita
Jan 9, 2003·Pharmacogenomics·Martin Alda
Feb 4, 2003·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Alessandro Serretti, Paola Artioli
Apr 11, 2013·Pharmacogenomics·Giovanni SeverinoMirko Manchia
May 4, 2010·Journal of Mental Health·Daniel J SmithNick Craddock
Jan 28, 2010·Expert Opinion on Pharmacotherapy·Falk W Lohoff, Thomas N Ferraro
Sep 30, 2008·Annals of Medicine·Martin AldaClaire O'Donovan
Mar 5, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·David A FishbainR Steele Rosomoff
Sep 14, 2010·Clinics in Laboratory Medicine·Peter P Zandi, Jennifer T Judy
Feb 18, 2010·The Psychiatric Clinics of North America·Peter P Zandi, Jennifer T Judy
May 6, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Alessio SquassinaMaria Del Zompo
Sep 8, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Takuya MasuiTsukasa Koyama
Oct 8, 2009·Acta Psychiatrica Scandinavica·P GrofT Hajek
May 20, 2003·Psychiatry and Clinical Neurosciences·Akifumi Ikeda, Tadafumi Kato
May 27, 2003·Alcoholism, Clinical and Experimental Research·Christina S BarrJ Dee Higley
Jun 14, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Klaus Peter Lesch, Lise Gutknecht
Feb 19, 2014·Pharmacology, Biochemistry, and Behavior·Adem CanTodd D Gould
May 16, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Allan V KalueffIrving I Gottesman
Mar 15, 2014·ACS Chemical Neuroscience·Janusz K Rybakowski
Feb 15, 2002·Bipolar Disorders·M Alda
Jul 17, 2004·The Australian and New Zealand Journal of Psychiatry·Chee Hong NgSimon Easteal
Sep 6, 2011·Journal of Psychopharmacology·Janusz K RybakowskiJoanna Hauser
Nov 6, 2003·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Martina RuzickovaMartin Alda
Nov 5, 2010·Pharmacogenomics·Michael J McCarthyJohn R Kelsoe
Mar 22, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Janusz K RybakowskiJoanna Hauser
Mar 20, 2008·Psychiatric Genetics·Thomas J StammMichael Bauer
Dec 9, 2008·International Clinical Psychopharmacology·Alessandro SerrettiDiana De Ronchi
Jan 22, 2004·European Journal of Human Genetics : EJHG·Julien MendlewiczChristine Van Broeckhoven

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.